Veracyte: Saving Lives, Avoiding Procedures! Veracyte's Molecular Tumor Tests Revolutionize Cancer Diagnostics!
Reading Time: 3 minutes
The "Healthcare" sector ranks in the middle of our standings. Although the "Diagnostics & Research” industry is lagging behind with -6.71%, the leader Veracyte managed to secure a gain of over 33% in the last month. What exactly does the company produce to justify this leap? Veracyte develops molecular tests for analyzing tumor biology Afirma has a 91% sensitivity in thyroid examinations Test volume increases by 17% to 47,615 units, profit growth at 307% Veracyte Inc. (VCYT) is a global diagnostics company that analyzes individual...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
